IMAX Corp (IMAX) shareholders
Close on Nov 17, 2026Market cap $2.58BP/E 65.4Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Kevin Douglas Joint filing with Michelle Douglas (11.20%), K&M Douglas Trust (6.70%) | 8,351,373 | 15.50% | 13D (active) amendment | Mar 16, 2026 |
| Orbis Investment Management Limited | 5,129,735 | 9.30% | 13G (passive) amendment | Jun 30, 2026 |
| Orbis Investment Management Ltd | 3,450,750 | 6.60% | 13G (passive) amendment | Dec 31, 2024 |
| FMR LLC Joint filing with Abigail P. Johnson (6.40%) | 3,435,348 | 6.40% | 13G (passive) amendment | Dec 31, 2025 |
| Nomura Asset Management International Inc. Joint filing with Nomura Investment Management Business Trust (5.40%) | 2,936,661 | 5.40% | 13G (passive) amendment | Jun 30, 2026 |
| GIC Private Limited | 2,866,544 | 5.23% | 13G (passive) | May 4, 2026 |
| BlackRock, Inc. | 2,840,348 | 5.20% | 13G (passive) | Jun 30, 2026 |
| Nantahala Capital Management, LLC Joint filing with Wilmot B. Harkey (5.28%), Daniel Mack (5.28%) | 2,778,774 | 5.28% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IMAX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Orbis Allan Gray Ltd | 5,149,555 | 9.39% | $205.26M | −2,166 | 0.71% |
| Nomura Asset Management International Inc. | 2,936,661 | 5.35% | $117.06M | −767,546 | 0.18% |
| BlackRock, Inc. | 2,907,192 | 5.30% | $115.88M | +284,602 | 0.00% |
| Westfield Capital Management Co LP | 2,654,014 | 4.84% | $105.79M | +315,238 | 0.35% |
| Congress Asset Management Co /Ma | 2,537,290 | 4.63% | $101.14M | +1,026,915 | 0.62% |
| Driehaus Capital Management LLC | 2,340,475 | 4.27% | $93.29M | +688,764 | 0.54% |
| FMR LLC | 2,322,400 | 4.23% | $92.57M | −794,974 | 0.00% |
| Ameriprise Financial Inc | 1,771,297 | 3.23% | $70.60M | +442,702 | 0.01% |
| Goldman Sachs Group Inc | 1,655,086 | 3.02% | $65.97M | +785,974 | 0.01% |
| JPMorgan Chase & Co | 1,450,626 | 2.65% | $58.79M | +480,056 | 0.00% |
| Price T Rowe Associates Inc /Md/ | 1,447,861 | 2.64% | $57.71M | +493,036 | 0.01% |
| Royce & Associates LP | 1,343,228 | 2.45% | $53.54M | +96,988 | 0.43% |
| Nantahala Capital Management, LLC | 1,316,018 | 2.40% | $52.46M | +800,464 | 0.87% |
| Dimensional Fund Advisors LP | 1,265,843 | 2.31% | $50.46M | +28,613 | 0.01% |
| Victory Capital Management Inc | 1,010,223 | 1.84% | $40.27M | −81,000 | 0.02% |
| State Street Corp | 963,761 | 1.76% | $38.43M | +65,266 | 0.00% |
| Marshall Wace, Llp | 841,035 | 1.53% | $33.52M | +312,653 | 0.03% |
| Emerald Advisers, LLC | 827,965 | 1.51% | $33.00M | −21,183 | 0.78% |
| Wellington Management Group Llp | 800,193 | 1.46% | $31.90M | +273,122 | 0.01% |
| Nuveen, LLC | 727,493 | 1.33% | $29.00M | +65,949 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 256 | 51M | 93.7% | 44 / 91 | 73 / 37 | 9M | 7M |
| Q1 2026 | 254 | 49M | 89.1% | 54 / 78 | 80 / 34 | 8M | 6M |
| Q4 2025 | 238 | 47M | 86.4% | 52 / 73 | 80 / 23 | 13M | 16M |
| Q3 2025 | 209 | 51M | 92.5% | 37 / 61 | 78 / 26 | 8M | 6M |
| Q2 2025 | 200 | 49M | 88.7% | 29 / 66 | 71 / 30 | 7M | 6M |
| Q1 2025 | 203 | 48M | 88.1% | 35 / 60 | 75 / 15 | 6M | 5M |
| Q4 2024 | 185 | 47M | 86.3% | 29 / 61 | 64 / 17 | 5M | 4M |
| Q3 2024 | 175 | 46M | 84.7% | 35 / 60 | 47 / 21 | 11M | 7M |
| Q2 2024 | 162 | 45M | 82.4% | 26 / 51 | 55 / 29 | 10M | 6M |
| Q1 2024 | 166 | 42M | 76.5% | 26 / 52 | 62 / 31 | 7M | 9M |
| Q4 2023 | 172 | 44M | 79.5% | 39 / 60 | 46 / 22 | 8M | 7M |
| Q3 2023 | 155 | 42M | 77.1% | 15 / 51 | 62 / 18 | 5M | 4M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
234 funds held IMAX in Q2 2026, 15% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of IMAX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Nomura Small Cap Core Fund | 1,797,361 | 3.28% | $71.32M | 1.29% | May 29, 2026 |
| Harbor Small Cap Growth Fund | 1,330,202 | 2.43% | $63.64M | 2.39% | Jul 31, 2026 |
| Congress Small Cap Growth Fund | 1,300,000 | 2.37% | $62.19M | 3.10% | Jul 31, 2026 |
| iShares Russell 2000 ETF | 1,201,253 | 2.19% | $47.88M | 0.06% | Jun 30, 2026 |
| Columbia Small Cap Growth Fund | 1,193,808 | 2.18% | $47.37M | 1.29% | May 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 980,200 | 1.79% | $38.89M | 0.02% | May 31, 2026 |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | 858,500 | 1.57% | $34.22M | 0.35% | Jun 30, 2026 |
| Victory Trivalent International Small-Cap Fund | 655,003 | 1.19% | $26.11M | 0.56% | Jun 30, 2026 |
| Lord Abbett Developing Growth Fund Inc | 615,420 | 1.12% | $29.44M | 1.32% | Jul 31, 2026 |
| JPMorgan Small Cap Growth Fund | 571,450 | 1.04% | $22.78M | 0.87% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 503,664 | 0.92% | $24.10M | 0.07% | Jul 31, 2026 |
| Fidelity Small Cap Growth Fund | 446,916 | 0.81% | $21.38M | 0.24% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 425,556 | 0.78% | $16.96M | 0.11% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF | 419,435 | 0.76% | $16.64M | 0.06% | May 31, 2026 |
| Royce Small-Cap Fund | 406,039 | 0.74% | $16.18M | 0.76% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Richard L. Gelfond | Chief Executive Officer, Director | 680,102 | 1.24% | Aug 20, 2026 |
| Giovanni M. Dolci | Chief Commercial Officer & EVP | 41,027 | 0.07% | Oct 2, 2026 |
| Robert D. Lister | Chief Legal Officer Sr Exec VP | 182,375 | 0.33% | Sep 11, 2026 |
| Mark Welton | President IMAX Global Theatres | 143,216 | 0.26% | Aug 26, 2026 |
| Natasha Fernandes | Chief Financial Officer & EVP | 35,596 | 0.06% | Aug 26, 2026 |
| Kenneth Ian Weissman | Deputy GC, Corp. Sec. & CCO | 28,205 | 0.05% | Aug 26, 2026 |
| Calamera Pablo | CTO & EVP | 43,012 | 0.08% | Aug 21, 2026 |
| Jose Aleksandr Zlatar | SVP, Controller & PAO | 583 | 0.00% | Aug 7, 2026 |
| Daniel Manwaring | CEO, IMAX China Holding, Inc. | 12,363 | 0.02% | Apr 6, 2026 |
| Jonathan Fischer | Chief Content Officer | 5,333 | 0.01% | Mar 10, 2026 |
| Michele Golden | Chief People Officer & EVP | 36,732 | 0.07% | Mar 10, 2026 |
| Anne Globe | Chief Marketing Officer | 18,574 | 0.03% | Mar 10, 2026 |
| Eric A. Demirian | Director | 40,483 | 0.07% | Jun 15, 2026 |
| Darren D. Throop | Director | 40,655 | 0.07% | Jun 15, 2026 |
| Dana R. Settle | Director | 69,090 | 0.13% | Jun 15, 2026 |
| Kevin Douglas | Director, 10% owner | 7,777,415 | 14.18% | Jun 15, 2026 |
| Michael MacMillan | Director | 39,569 | 0.07% | Jun 15, 2026 |
| Steve Pamon | Director | 35,515 | 0.06% | Jun 15, 2026 |
| Gail Berman | Director | 22,582 | 0.04% | Jun 15, 2026 |
| Jennifer L. Wong | Director | 22,582 | 0.04% | Jun 15, 2026 |
| David W. Leebron | Director | 132,383 | 0.24% | Jun 15, 2026 |
| Financial Llc Celtic | – | 8,943,167 | 16.31% | Jun 15, 2026 |
| James E. Douglas Iii | – | 8,383,115 | 15.29% | Jun 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert D. Lister Chief Legal Officer Sr Exec VP | Sep 10, 2026 | Sale | −22,500 | $51.58 | $1.16M | 182,375 |
| Mark Welton President IMAX Global Theatres | Aug 25, 2026 | Sale | −30,000 | $54.47 | $1.63M | 143,216 |
| Kenneth Ian Weissman Deputy GC, Corp. Sec. & CCO | Aug 25, 2026 | Sale | −8,000 | $54.54 | $436.32K | 28,205 |
| Natasha Fernandes Chief Financial Officer & EVP | Aug 24, 2026 | Sale | −20,000 | $54.63 | $1.09M | 35,596 |
| Calamera Pablo CTO & EVP | Aug 20, 2026 | Sale | −15,000 | $52.41 | $786.15K | 43,012 |
| Richard L. Gelfond Chief Executive Officer, Director | Aug 20, 2026 | Sale(10b5-1 plan) | −100,000 | $53.23 | $5.32M | 665,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Aug 19, 2026 | Conversion | +205,504 | $31.90 | $6.56M | 970,506 |
| Richard L. Gelfond Chief Executive Officer, Director | Aug 19, 2026 | Sale(10b5-1 plan) | −205,504 | $53.27 | $10.95M | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Aug 18, 2026 | Sale(10b5-1 plan) | −151,253 | $51.00 | $7.71M | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Aug 18, 2026 | Conversion | +151,253 | $31.90 | $4.82M | 916,255 |
| Jose Aleksandr Zlatar SVP, Controller & PAO | Aug 6, 2026 | Sale | −500 | $49.90 | $24.95K | 583 |
| Michael MacMillan Director | Jun 11, 2026 | Tax withholding | −1,849 | $42.12 | $77.88K | 39,569 |
| Michael MacMillan Director | Jun 11, 2026 | Option exercise | +3,390 | – | – | 41,418 |
| Jennifer L. Wong Director | Jun 11, 2026 | Option exercise | +3,390 | – | – | 22,582 |
| Dana R. Settle Director | Jun 11, 2026 | Option exercise | +3,390 | – | – | 69,090 |
| Gail Berman Director | Jun 11, 2026 | Option exercise | +3,390 | – | – | 22,582 |
| Steve Pamon Director | Jun 11, 2026 | Option exercise | +3,390 | – | – | 35,515 |
| Eric A. Demirian Director | Jun 11, 2026 | Option exercise | +3,390 | – | – | 40,483 |
| Eric A. Demirian Director | Jun 11, 2026 | Tax withholding | −1,842 | $42.12 | $77.59K | 38,641 |
| Darren D. Throop Director | Jun 11, 2026 | Option exercise | +4,611 | – | – | 40,655 |
| Darren D. Throop Director | Jun 11, 2026 | Tax withholding | −2,474 | $42.12 | $104.20K | 38,181 |
| James E. Douglas Iii – | Jun 11, 2026 | Award | +3,390 | – | – | 3,660,840 |
| David W. Leebron Director | Jun 11, 2026 | Option exercise | +3,390 | – | – | 131,083 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 27, 2026 | Sale(10b5-1 plan) | −8,943 | $37.33 | $333.84K | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 27, 2026 | Conversion | +8,943 | $31.40 | $280.81K | 773,945 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 17, 2026 | Conversion | +34,182 | $31.40 | $1.07M | 799,184 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 17, 2026 | Sale(10b5-1 plan) | −34,182 | $37.06 | $1.27M | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 16, 2026 | Conversion | +41,737 | $31.40 | $1.31M | 806,739 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 16, 2026 | Sale(10b5-1 plan) | −41,737 | $37.05 | $1.55M | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 15, 2026 | Sale(10b5-1 plan) | −15,746 | $37.07 | $583.70K | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 15, 2026 | Conversion | +15,746 | $31.40 | $494.42K | 780,748 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 14, 2026 | Sale(10b5-1 plan) | −6,924 | $37.07 | $256.67K | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 14, 2026 | Conversion | +6,924 | $31.40 | $217.41K | 771,926 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 13, 2026 | Conversion | +97,462 | $31.40 | $3.06M | 862,464 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 13, 2026 | Sale(10b5-1 plan) | −97,462 | $37.15 | $3.62M | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 10, 2026 | Conversion | +135,046 | $31.40 | $4.24M | 900,048 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 10, 2026 | Sale(10b5-1 plan) | −135,046 | $37.82 | $5.11M | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 6, 2026 | Conversion | +12,987 | $31.40 | $407.79K | 777,989 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 6, 2026 | Sale(10b5-1 plan) | −12,987 | $40.26 | $522.86K | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 2, 2026 | Sale(10b5-1 plan) | −12,037 | $40.00 | $481.48K | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Apr 2, 2026 | Conversion | +12,037 | $31.40 | $377.96K | 777,039 |
| Kevin Douglas Director, 10% owner | Mar 16, 2026 | Sale | −43,800 | $37.82 | $1.66M | 602,310 |
| Kevin Douglas Director, 10% owner | Mar 16, 2026 | Sale | −330,200 | $37.82 | $12.49M | 3,657,450 |
| Kevin Douglas Director, 10% owner | Mar 16, 2026 | Sale | −43,800 | $37.82 | $1.66M | 602,310 |
| Kevin Douglas Director, 10% owner | Mar 16, 2026 | Sale | −62,600 | $37.82 | $2.37M | 1,301,045 |
| Kevin Douglas Director, 10% owner | Mar 16, 2026 | Sale | −43,800 | $37.82 | $1.66M | 602,310 |
| Kevin Douglas Director, 10% owner | Mar 16, 2026 | Sale | −43,800 | $37.82 | $1.66M | 602,311 |
| Richard L. Gelfond Chief Executive Officer, Director | Mar 10, 2026 | Sale(10b5-1 plan) | −121,220 | $40.10 | $4.86M | 765,002 |
| Richard L. Gelfond Chief Executive Officer, Director | Mar 10, 2026 | Conversion | +121,220 | $31.40 | $3.81M | 886,222 |
| Daniel Manwaring CEO, IMAX China Holding, Inc. | Mar 7, 2026 | Tax withholding | −4,790 | $40.80 | $195.43K | 12,363 |
| Daniel Manwaring CEO, IMAX China Holding, Inc. | Mar 7, 2026 | Option exercise | +4,666 | – | – | 17,153 |
| Daniel Manwaring CEO, IMAX China Holding, Inc. | Mar 7, 2026 | Option exercise | +7,409 | – | – | 12,487 |
| Giovanni M. Dolci Chief Commercial Officer & EVP | Mar 7, 2026 | Option exercise | +2,682 | – | – | 35,682 |
| Giovanni M. Dolci Chief Commercial Officer & EVP | Mar 7, 2026 | Option exercise | +4,445 | – | – | 40,127 |
| Giovanni M. Dolci Chief Commercial Officer & EVP | Mar 7, 2026 | Option exercise | +3,333 | – | – | 43,460 |
| Giovanni M. Dolci Chief Commercial Officer & EVP | Mar 7, 2026 | Tax withholding | −2,205 | $40.80 | $89.96K | 41,027 |
| Giovanni M. Dolci Chief Commercial Officer & EVP | Mar 7, 2026 | Award | +4,690 | – | – | 43,232 |
| Giovanni M. Dolci Chief Commercial Officer & EVP | Mar 7, 2026 | Tax withholding | −4,918 | $40.80 | $200.65K | 38,542 |
| Robert D. Lister Chief Legal & Sr Exec VP | Mar 7, 2026 | Award | +40,817 | – | – | 217,621 |
| Robert D. Lister Chief Legal & Sr Exec VP | Mar 7, 2026 | Option exercise | +12,959 | – | – | 172,380 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of IMAX's stock actually held short. Settlement fails (shares not delivered on time) peaked at 181,402 shares on Aug 20, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Robert D. Lister Officer | Sep 10, 2026 | 22,500 | $1.16M | Sep 10, 2026 | Vesting of restricted stock units |
| Kenneth Ian Weissman Officer | Aug 25, 2026 | 8,000 | $436.29K | Aug 25, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Mark Welton Officer | Aug 25, 2026 | 30,000 | $1.63M | Aug 25, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Natasha Fernandes Officer | Aug 24, 2026 | 20,000 | $1.09M | Aug 24, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Richard L. Gelfond Officer | Aug 20, 2026 | 100,000 | $5.27M | Aug 20, 2026 | Acquired as compensation -- Restricted Stock Units |
| Calamera Pablo Officer | Aug 20, 2026 | 15,000 | $786.17K | Aug 20, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Richard L. Gelfond Officer | Aug 19, 2026 | 205,504 | $11.04M | Aug 19, 2026 | Acquired as compensation -- Stock Options |
| Richard L. Gelfond Officer | Aug 18, 2026 | 151,253 | $7.65M | Aug 18, 2026 | Acquired as compensation -- Stock Options |
| Jose Aleksandr Zlatar Officer | Aug 6, 2026 | 500 | $24.95K | Aug 6, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Richard L. Gelfond Officer | Apr 27, 2026 | 8,943 | $331.96K | Apr 27, 2026 | Acquired as compensation -- Stock Options |
| Richard L. Gelfond Officer | Apr 17, 2026 | 34,182 | $1.20M | Apr 17, 2026 | Acquired as compensation -- Stock Options |
| Richard L. Gelfond Officer | Apr 16, 2026 | 41,737 | $1.55M | Apr 16, 2026 | Acquired as compensation -- Stock Options |
| Richard L. Gelfond Officer | Apr 15, 2026 | 15,746 | $583.55K | Apr 15, 2026 | Acquired as compensation -- Stock Options |
| Richard L. Gelfond Officer | Apr 14, 2026 | 6,924 | $255.01K | Apr 14, 2026 | Acquired as compensation -- Stock Options |
| Richard L. Gelfond Officer | Apr 13, 2026 | 97,462 | $3.60M | Apr 13, 2026 | Acquired as compensation -- Stock Options |
Congress trades
6 trades in IMAX reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Earl Blumenauer OR03 · spouse | Sold | Jun 17, 2022 | $1K–15K | Jul 6, 2022 |
| Earl Blumenauer OR03 · spouse | Sold (part) | Jun 16, 2022 | $1K–15K | Jul 6, 2022 |
| Earl Blumenauer OR03 · spouse | Bought | Feb 11, 2022 | $1K–15K | Mar 7, 2022 |
| Earl Blumenauer OR03 | Bought | Feb 28, 2018 | $1K–15K | Mar 6, 2018 |
| Thomas MacArthur NJ03 · joint account | Sold | May 27, 2015 | $1K–15K | Jun 7, 2015 |
| Thomas MacArthur NJ03 · joint account | Bought | Feb 4, 2015 | $1K–15K | Mar 11, 2015 |
See a number that looks wrong?